218 related articles for article (PubMed ID: 22957045)
1. Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation.
Ridnour LA; Barasch KM; Windhausen AN; Dorsey TH; Lizardo MM; Yfantis HG; Lee DH; Switzer CH; Cheng RY; Heinecke JL; Brueggemann E; Hines HB; Khanna C; Glynn SA; Ambs S; Wink DA
PLoS One; 2012; 7(9):e44081. PubMed ID: 22957045
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and IGF-I activate the Akt pathway in breast cancer.
Prueitt RL; Boersma BJ; Howe TM; Goodman JE; Thomas DD; Ying L; Pfiester CM; Yfantis HG; Cottrell JR; Lee DH; Remaley AT; Hofseth LJ; Wink DA; Ambs S
Int J Cancer; 2007 Feb; 120(4):796-805. PubMed ID: 17096325
[TBL] [Abstract][Full Text] [Related]
3. Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.
Ambs S; Glynn SA
Cell Cycle; 2011 Feb; 10(4):619-24. PubMed ID: 21293193
[TBL] [Abstract][Full Text] [Related]
4. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
Switzer CH; Cheng RY; Ridnour LA; Glynn SA; Ambs S; Wink DA
Breast Cancer Res; 2012 Sep; 14(5):R125. PubMed ID: 22971289
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).
Bernert B; Porsch H; Heldin P
J Biol Chem; 2011 Dec; 286(49):42349-42359. PubMed ID: 22016393
[TBL] [Abstract][Full Text] [Related]
6. Tissue inhibitor of metalloproteinase-1 decreased chemosensitivity of MDA-435 breast cancer cells to chemotherapeutic drugs through the PI3K/AKT/NF-кB pathway.
Fu ZY; Lv JH; Ma CY; Yang DP; Wang T
Biomed Pharmacother; 2011 Jun; 65(3):163-7. PubMed ID: 21684102
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.
Heinecke JL; Ridnour LA; Cheng RY; Switzer CH; Lizardo MM; Khanna C; Glynn SA; Hussain SP; Young HA; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6323-8. PubMed ID: 24733928
[TBL] [Abstract][Full Text] [Related]
8. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1.
Liu XW; Taube ME; Jung KK; Dong Z; Lee YJ; Roshy S; Sloane BF; Fridman R; Kim HR
Cancer Res; 2005 Feb; 65(3):898-906. PubMed ID: 15705888
[TBL] [Abstract][Full Text] [Related]
9. The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling.
Rossi L; Forte D; Migliardi G; Salvestrini V; Buzzi M; Ricciardi MR; Licchetta R; Tafuri A; Bicciato S; Cavo M; Catani L; Lemoli RM; Curti A
Exp Hematol; 2015 Nov; 43(11):974-985.e1. PubMed ID: 26213230
[TBL] [Abstract][Full Text] [Related]
10. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
[TBL] [Abstract][Full Text] [Related]
11. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer.
Switzer CH; Glynn SA; Cheng RY; Ridnour LA; Green JE; Ambs S; Wink DA
Mol Cancer Res; 2012 Sep; 10(9):1203-15. PubMed ID: 22878588
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
Basudhar D; Glynn SA; Greer M; Somasundaram V; No JH; Scheiblin DA; Garrido P; Heinz WF; Ryan AE; Weiss JM; Cheng RYS; Ridnour LA; Lockett SJ; McVicar DW; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13030-13035. PubMed ID: 29087320
[TBL] [Abstract][Full Text] [Related]
14. BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
Bommarito A; Richiusa P; Carissimi E; Pizzolanti G; Rodolico V; Zito G; Criscimanna A; Di Blasi F; Pitrone M; Zerilli M; Amato MC; Spinelli G; Carina V; Modica G; Latteri MA; Galluzzo A; Giordano C
Endocr Relat Cancer; 2011 Dec; 18(6):669-85. PubMed ID: 21903858
[TBL] [Abstract][Full Text] [Related]
15. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
16. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
J Cell Biochem; 2012 Dec; 113(12):3653-62. PubMed ID: 22740037
[TBL] [Abstract][Full Text] [Related]
17. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
Qiu Q; Yang M; Tsang BK; Gruslin A
Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
[TBL] [Abstract][Full Text] [Related]
18. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
[TBL] [Abstract][Full Text] [Related]
19. COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer.
Glynn SA; Prueitt RL; Ridnour LA; Boersma BJ; Dorsey TM; Wink DA; Goodman JE; Yfantis HG; Lee DH; Ambs S
BMC Cancer; 2010 Nov; 10():626. PubMed ID: 21078168
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1.
Ridnour LA; Dhanapal S; Hoos M; Wilson J; Lee J; Cheng RY; Brueggemann EE; Hines HB; Wilcock DM; Vitek MP; Wink DA; Colton CA
J Neurochem; 2012 Dec; 123(5):736-49. PubMed ID: 23016931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
